Acuren Corporation has announced the successful completion of its re-domiciliation process, officially transitioning from the British Virgin Islands to a Delaware-based corporation. The move follows the U.S. Securities and Exchange Commission (SEC) declaring its Registration Statement on Form S-4 (File No. 333-282976) effective as of December 16, 2024.
Acuren’s leadership confirmed that its common stock is expected to commence trading on the OTC Market before the year-end. The company further revealed plans to apply for a listing on the prestigious New York Stock Exchange (NYSE) during the first quarter of 2025, marking a significant milestone in its growth trajectory.
About Acuren Corporation
Acuren is a leading provider of critical asset integrity services across North America, serving industrial markets with a focus on Testing, Inspection, and Certification (TIC) solutions. Its expertise spans Nondestructive Testing (NDT), both in the field and laboratory, as well as destructive testing. Acuren’s essential services support recurring maintenance programs, ensuring asset safety, reliability, and compliance. For more information, visit www.acuren.com.
Disclaimer:
This news release does not constitute an offer to buy or sell securities. It contains forward-looking statements regarding the trading of Acuren’s common stock and its anticipated listing on the NYSE. These statements are subject to risks and uncertainties, and readers are advised not to place undue reliance on them. Acuren undertakes no obligation to update forward-looking statements unless required by law.
